Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Ishida

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Pediatric Blood & Cancer|June 9, 2015
Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell TransplantationMotohiro Kato, Hiroyuki Ishida, Katsuyoshi Koh, et al.
Cancer Research|April 9, 2009
K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cellsRyuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, et al.
Pediatric Blood & Cancer|October 2, 2018
Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in JapanHirotoshi Sakaguchi, Hideki Muramatsu, Daiichiro Hasegawa, et al.
The Kurume Medical Journal|August 23, 2021
Single-Arm Non-Blinded Multicenter Clinical Trial on T-Cell-Replete Haploidentical Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin for Relapsed and Refractory Pediatric Acute LeukemiaAkiko Kada, Atsushi Kikuta, Akiko M Saito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 15, 2015
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell TransplantationHiroyuki Ishida, Motohiro Kato, Kazuko Kudo, et al.
Bone Marrow Transplantation|March 11, 2021
Effect of extramedullary disease on allogeneic hematopoietic cell transplantation for pediatric acute myeloid leukemia: a nationwide retrospective studyHirotoshi Sakaguchi, Takako Miyamura, Daisuke Tomizawa, et al.
Bone Marrow Transplantation|February 6, 2019
Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemiaYasuhiro Okamoto, Kazuko Kudo, Ken Tabuchi, et al.
BMJ Open|April 17, 2023
Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I-II, multicentre, non-blinded, non-controlled trial (JPLSG SCT-ALL-BLIN21)Hirotoshi Sakaguchi, Katsustugu Umeda, Itaru Kato, et al.
International Journal of Hematology|March 14, 2019
High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS)Hisanori Fujino, Hiroyuki Ishida, Akihiro Iguchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2017
Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid LeukemiaDaisuke Tomizawa, Shiro Tanaka, Tadakazu Kondo, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Pediatric Blood & Cancer|June 9, 2015
Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell TransplantationMotohiro Kato, Hiroyuki Ishida, Katsuyoshi Koh, et al.
Cancer Research|April 9, 2009
K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cellsRyuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, et al.
Pediatric Blood & Cancer|October 2, 2018
Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in JapanHirotoshi Sakaguchi, Hideki Muramatsu, Daiichiro Hasegawa, et al.
The Kurume Medical Journal|August 23, 2021
Single-Arm Non-Blinded Multicenter Clinical Trial on T-Cell-Replete Haploidentical Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin for Relapsed and Refractory Pediatric Acute LeukemiaAkiko Kada, Atsushi Kikuta, Akiko M Saito, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 15, 2015
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell TransplantationHiroyuki Ishida, Motohiro Kato, Kazuko Kudo, et al.
Bone Marrow Transplantation|March 11, 2021
Effect of extramedullary disease on allogeneic hematopoietic cell transplantation for pediatric acute myeloid leukemia: a nationwide retrospective studyHirotoshi Sakaguchi, Takako Miyamura, Daisuke Tomizawa, et al.
Bone Marrow Transplantation|February 6, 2019
Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemiaYasuhiro Okamoto, Kazuko Kudo, Ken Tabuchi, et al.
BMJ Open|April 17, 2023
Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I-II, multicentre, non-blinded, non-controlled trial (JPLSG SCT-ALL-BLIN21)Hirotoshi Sakaguchi, Katsustugu Umeda, Itaru Kato, et al.
International Journal of Hematology|March 14, 2019
High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS)Hisanori Fujino, Hiroyuki Ishida, Akihiro Iguchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2017
Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid LeukemiaDaisuke Tomizawa, Shiro Tanaka, Tadakazu Kondo, et al.
Pageof 22